Kenta Uchibe

Kenta Uchibe

Auto-generated profile, based on publicly available information

Kenta Uchibe

Department of Maxillofacial Anatomy and Neuroscience, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2019 in Anatomical Science International
Verified
Journal Article
Closed access
PDF file
YSYusuke Sumitani
Yusuke Sumitani
KUKenta Uchibe
Kenta Uchibe
KYKayo Yoshida
Kayo Yoshida
YWYao Weng
Yao Weng
JGJiajie Guo
Jiajie Guo
HOHirohiko Okamura
Hirohiko Okamura

27 December 2025 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
SOSAKI OGAWA
SAKI OGAWA
SHShinnosuke Higuchi
Shinnosuke Higuchi
YYYuki Yoshimoto
Yuki Yoshimoto
MHMari Hoshino
Mari Hoshino
SMShigenori Miura
Shigenori Miura
CSChisa Shukunami
Chisa Shukunami
Runt-related transcription factor 2 (RUNX2) is essential for skeletogenesis, and mutations in its gene cause cleidocranial dysplasia (CCD), an autosomal dominant skeletal disorder. The evolutionarily conserved 128-amino acid Runt homology domain (RHD) of human RUNX2 is essential for DNA binding and heterodimerization, and serves as a mutation hotspot associated with severe CCD phenotypes. To elucidate the functional impact of pathogenic RHD mutations in vivo, we generated 2 novel mouse lines: one carrying a missense mutation, c.695G>A, p.Arg232Gln (p.R232Q), corresponding to the human RUNX2 c.674G>A, p.Arg225Gln (p.R225Q), and the other harboring a frameshift mutation, c.697_698delGA, p.Glu233Thrfs*9 (p.E233Tfs*9), causing a premature stop codon. Homozygous Runx2R232Q/R232Q and Runx2E233Tfs*9/E233Tfs*9 mice lacked membranous ossification, whereas heterozygous Runx2R232Q/+ and Runx2E233Tfs*9/+ mice displayed typical CCD-like skeletal features, including an open anterior fontanelle and clavicle hypoplasia. Unexpectedly, heterozygotes carrying pathogenic RHD mutations developed small root-like protrusions, mostly 1 but rarely 2, at the pulp chamber floor of 3-rooted maxillary first molars during furcation, revealing a previously unrecognized dental phenotype. Dual luciferase assays showed that p.R232Q almost completely lost transactivation of the osteocalcin enhancer/promoter. Immunostaining showed that wild-type Runx2 was robustly expressed in osteoblasts and hypertrophic chondrocytes during bone formation, while the p.R232Q mutant Runx2 in Runx2R232Q/R232Q mice exhibited reduced expression in hypertrophic chondrocytes and partially impaired nuclear localization. These abnormalities led to defective osteoblast differentiation and chondrocyte maturation. Thus, our mutant mouse model provides a valuable in vivo platform to study CCD pathogenesis, mechanisms of tooth root furcation, and therapeutic interventions targeting dysfunctional RHD.

30 January 2025 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
MMMasatake Matsuoka
Masatake Matsuoka
KUKenta Uchibe
Kenta Uchibe
NTNingfeng Tang
Ningfeng Tang
HTHongying Tian
Hongying Tian
ASAkiko Suzuki
Akiko Suzuki
MIMasahiro Iwamoto
Masahiro Iwamoto
Growth-plate (GP) injures in limbs and other sites can impair GP function and cause deceleration of bone growth, leading to progressive bone lengthening imbalance, deformities and/or physical discomfort, decreased motion and pain. At present, surgical interventions are the only means available to correct these conditions by suppressing the GP activity in the unaffected limb and/or other bones in the ipsilateral region. Here, we aimed to develop a pharmacologic treatment of GP growth imbalance that involves local application of nanoparticles (NP)-based controlled release of a selective retinoic acid nuclear receptor gamma (RARγ) agonist drug. When RARγ agonist-loaded NP were implanted near the medial and lateral sides of proximal tibial growth plate in juvenile C57BL/6J mice, the GP underwent involution and closure. Overall tibia length was shortened compared to the contralateral element implanted with drug-free control NP. Importantly, when the RARγ agonist NP were implanted on the lateral side only, the adjacent epiphysis tilted toward the lateral side, leading to apical angulation of the tibia. In contrast to the local selectivity of these responses, systemic administration of RARγ agonists led to GP closure at many sites, inhibiting skeletal growth over time. Agonists for RARα and RARβ elicited no obvious responses over parallel regimens. Our findings provide novel evidence that RARγ agonist-loaded NP can control activity, function and directionality of a targeted GP, offering a potential and clinically-relevant alternative or supplementation to surgical correction of limb length discrepancy and angular deformities.

15 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SYShinsei Yambe
Shinsei Yambe
YYYuki Yoshimoto
Yuki Yoshimoto
KIKazutaka Ikeda
Kazutaka Ikeda
KMKoichiro Maki
Koichiro Maki
ATAki Takimoto
Aki Takimoto
CSChisa Shukunami
Chisa Shukunami
Fibrocartilaginous entheses consist of four graded tissue layers including tendon, the unmineralized and mineralized fibrocartilage, and subchondral bone with varying degrees of stiffness. Here we examined the functional role of sclerostin that is expressed in mature mineralized fibrochondrocytes. Following rapid mineralization of the unmineralized fibrocartilage and parallel replacement of epiphyseal hyaline cartilage by bone, the unmineralized fibrocartilage re-expanded after a decline in alkaline phosphatase activity at the mineralization front. Sclerostin was co-expressed with osteocalcin in the bottom of the mineralized fibrocartilage adjacent to subchondral bone. In Scx deficient mice with less mechanical loading due to defects of the Achilles tendon, the number of sclerostin + fibrochondrocytes was significantly reduced in the defective enthesis where chondrocyte maturation was markedly impaired in both fibrocartilage and hyaline cartilage. Loss of the Sost gene, coding for sclerostin, caused increased mineral density in the mineralized zones of the fibrocartilaginous enthesis. Atomic force microscopy analysis revealed the higher stiffness of fibrocartilage. These lines of evidence suggest that sclerostin in mature mineralized fibrochondrocytes acts as a modulator for mechanical tissue integrity of the fibrocartilaginous enthesis.

6 April 2026 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SOShun Ogata
Shun Ogata
SIShota Ito
Shota Ito
RKRyo Kunimatsu
Ryo Kunimatsu
SOSAKI OGAWA
SAKI OGAWA
KUKenta Uchibe
Kenta Uchibe
KTKotaro Tanimoto
Kotaro Tanimoto